{
    "clinical_study": {
        "@rank": "68685", 
        "arm_group": [
            {
                "arm_group_label": "pantoprazole", 
                "arm_group_type": "Experimental", 
                "description": "Intravenous pantoprazole 40 mg flacon"
            }, 
            {
                "arm_group_label": "ranitidine", 
                "arm_group_type": "Active Comparator", 
                "description": "Intravenous ranitidine 50 mg"
            }
        ], 
        "brief_summary": {
            "textblock": "The H0 hypothesis of the study there is no difference between pantoprazole and ranitidine in\n      treating patients presented with dyspepsia to the emergency deparment.\n\n      The H1 hypothesis is there is difference between pantoprazole and ranitidine in treating\n      patients presented with dyspepsia to the emergency department."
        }, 
        "brief_title": "Comparison of Pantoprazole and Ranitidine in Dyspepsia", 
        "completion_date": {
            "#text": "January 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Dyspepsia", 
        "condition_browse": {
            "mesh_term": "Dyspepsia"
        }, 
        "detailed_description": {
            "textblock": "Dyspepsia is one of the common complaints in emergency department. Protone pomp inhibitors,\n      H2 receptor blockers and anti-acids are common drugs for treating dyspepsia in emergency\n      department. However there is no study in the emergency department comparing the\n      effectiveness of these drugs. So the investigators planned this study which drug is\n      effective in these patients in order to provide a cost-effective treatment in dyspeptic\n      patients."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Epigastric pain\n\n          -  Older than 18 years old\n\n        Exclusion Criteria:\n\n          -  Diagnosed as cholecystitis, pancreatitis, myocardial infarction, etc.. at the end of\n             the emergency deparment evaluation period.\n\n          -  Pregnancy\n\n          -  Patients with unstable vital signs\n\n          -  Patients used anti-acid, H2 receptor blockers and proton pomp inhibitors in the last\n             one hour.\n\n          -  Allergy to H2 receptor blockers and proton pomp inhibitors.\n\n          -  Patients denied to give inform consent and who are illiterate"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "70", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 24, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01737840", 
            "org_study_id": "160"
        }, 
        "intervention": [
            {
                "arm_group_label": "pantoprazole", 
                "intervention_name": "Pantoprazole", 
                "intervention_type": "Drug", 
                "other_name": "Pantpas"
            }, 
            {
                "arm_group_label": "ranitidine", 
                "intervention_name": "Ranitidine", 
                "intervention_type": "Drug", 
                "other_name": "Ulcuran"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Ranitidine", 
                "Ranitidine bismuth citrate", 
                "Pantoprazole"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "dyspepsia", 
            "pantoprazole", 
            "ranitidine", 
            "emergency department"
        ], 
        "lastchanged_date": "November 29, 2012", 
        "link": {
            "description": "The web adress of the organization which this study is conducted.", 
            "url": "http://www.akdeniz.edu.tr"
        }, 
        "location": {
            "contact": {
                "email": "cenkereken@akdeniz.edu.tr", 
                "last_name": "Cenker Eken, Proffesor", 
                "phone": "00905056251217"
            }, 
            "facility": {
                "address": {
                    "city": "Antalya", 
                    "country": "Turkey", 
                    "zip": "07050"
                }, 
                "name": "Akdeniz University"
            }, 
            "investigator": {
                "last_name": "Engin Senay, Resident", 
                "role": "Sub-Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Turkey"
        }, 
        "number_of_arms": "2", 
        "official_title": "Intravenous Pantoprazole vs Ranitidine in Dyspepsia in Emergency Department: A Randomized Controlled Trial.", 
        "overall_contact": {
            "email": "cenkereken@akdeniz.edu.tr", 
            "last_name": "Cenker Eken, Proffesor", 
            "phone": "00905056251217"
        }, 
        "overall_official": {
            "affiliation": "Akdeniz University", 
            "last_name": "Cenker Eken, Proffesor", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Turkey: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "January 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The investigators are measuring the change of pain from the baseline to the 30th and 60th minutes by visual anologue scale.", 
            "measure": "Visual analogue scale score", 
            "safety_issue": "No", 
            "time_frame": "30th and 60th minutes"
        }, 
        "reference": {
            "PMID": "2202240", 
            "citation": "Welling LR, Watson WA. The emergency department treatment of dyspepsia with antacids and oral lidocaine. Ann Emerg Med. 1990 Jul;19(7):785-8."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01737840"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "The investigators are measuring the need for additional drug at the end of 60 minutes.", 
            "measure": "Need for additional drug", 
            "safety_issue": "No", 
            "time_frame": "60 th minute"
        }, 
        "source": "Akdeniz University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Akdeniz University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2012"
    }
}